Today’s top gainers include the company Merck & Co. Inc. (NYSE:MRK) which is in the industry Drug Manufacturers – Major, gaining -0.75% today. In the last week its performance is 6.44%, and 7.21% for the past quarter. Currently, Merck & Co. Inc., MRK has a target price of 61.45, so today’s gain of -0.75% is a significant step towards its target price. The GAP today is therefore -0.27%.
Merck & Co. Inc. (NYSE:MRK), has a market cap of 164109.84, and is based in USA. Insider ownership is at 0.04%, and institutional ownership is 74.90%.
At the current price of 58.72, it has a dividend yield of 3.11%, and its target price is 61.45. This is with a profit margin of 11.70%, and total debt/equity of 0.59. Merck & Co. Inc. (NYSE:MRK) has a P/E of 36.18, as well as a forward P/E of 15.74.
With a current EPS of 1.64, and a forecasted EPS growth for next year at 1.13%,Merck & Co. Inc. (NYSE:MRK) has had a EPS growth for the past five years at 41.50%. For the next five years EPS growth is projected to be 3.35%.
Performance for the year is 5.55%. Since its IPO date on 01/02/1970, the total performance to date is 13.91%.
Volume today for Merck & Co. Inc. (NYSE:MRK), is 2888108, while its average volume is 8881.85. Whilst the total gain today was -0.75%, it did have a day high of -0.94%.
Volatility for this week has been at 1.44%, and 1.45% for the month. The 52-week low for Merck & Co. Inc., MRK has been 32.95%, while the 52-week-high has reached -0.94%.
Looking at its return of investments, which is 6.40%, and its return on assets is 4.60%. Merck & Co. Inc. (NYSE:MRK) has an operating margin of 18.20%. With a sales growth of -1.20% quarter over quarter. Bearing in mind that Merck & Co. Inc., MRK is in the sector Healthcare, its long-term debt/equity is 0.54, and has a current ratio of 1.6 and 1.3 for quick ratio.
So what is the value of Merck & Co. Inc.? Well its PEG is 10.8, and the P/S is 4.17, along with a P/B of 3.75. Meanwhile it has a p/cash of 12.68.